Enanta Pharmaceuticals (ENTA) Amortizatization of Intangibles (2016 - 2025)
Enanta Pharmaceuticals filings provide 14 years of Amortizatization of Intangibles readings, the most recent being -$20000.0 for Q4 2025.
- On a quarterly basis, Amortizatization of Intangibles rose 96.84% to -$20000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $109000.0, a 86.03% decrease, with the full-year FY2025 number at -$503000.0, down 144.2% from a year prior.
- Amortizatization of Intangibles hit -$20000.0 in Q4 2025 for Enanta Pharmaceuticals, down from $958000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.4 million in Q2 2023 to a low of -$816000.0 in Q1 2025.
- Median Amortizatization of Intangibles over the past 5 years was -$39000.0 (2022), compared with a mean of $30750.0.
- Biggest five-year swings in Amortizatization of Intangibles: skyrocketed 1778.12% in 2024 and later tumbled 3164.0% in 2025.
- Enanta Pharmaceuticals' Amortizatization of Intangibles stood at -$546000.0 in 2021, then surged by 162.09% to $339000.0 in 2022, then plummeted by 180.83% to -$274000.0 in 2023, then plummeted by 130.66% to -$632000.0 in 2024, then skyrocketed by 96.84% to -$20000.0 in 2025.
- The last three reported values for Amortizatization of Intangibles were -$20000.0 (Q4 2025), $958000.0 (Q3 2025), and -$13000.0 (Q2 2025) per Business Quant data.